NurExone Biologic Inc. (TSXV:NRX)
Canada · Delayed Price · Currency is CAD 0.4900
-0.0050 (-1.01%)
Aug 10, 2026, 10:21 AM EST
NurExone Biologic Market Cap
NurExone Biologic has a market cap or net worth of CAD 46.06 million as of August 10, 2026. Its market cap has decreased by -16.56% in one year.
Market Cap
46.06M
Enterprise Value
44.05M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.49
ChartMarket Cap Chart
Since June 23, 2022, NurExone Biologic's market cap has increased from 33.48M to 46.06M, an increase of 37.57%. That is a compound annual growth rate of 8.02%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 10, 2026 | 45.60M | -23.81% |
| Dec 31, 2025 | 59.85M | 36.16% |
| Dec 31, 2024 | 43.95M | 208.80% |
| Dec 28, 2023 | 14.23M | -14.84% |
| Dec 22, 2022 | 16.71M | -50.08% |
| Jun 23, 2022 | 33.48M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Onco-Innovations | 44.40M |
| BriaCell Therapeutics | 44.11M |
| Sernova Biotherapeutics | 43.43M |
| MedMira | 42.10M |
| Microbix Biosystems | 39.95M |
| Sona Nanotech | 38.32M |
| Telescope Innovations | 34.76M |
| Medicenna Therapeutics | 34.61M |